High and low EPS estimates for Veracyte Inc. (VCYT)’s current quarter

As of close of business last night, Veracyte Inc.’s stock clocked out at $26.00, down -1.10% from its previous closing price of $26.29. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 597988 shares were traded. VCYT stock price reached its highest trading level at $27.26 during the session, while it also had its lowest trading level at $25.99.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



To gain a deeper understanding of VCYT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 267.36. For the most recent quarter (mrq), Quick Ratio is recorded 4.30 and its Current Ratio is at 4.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 14 when Anderson Bonnie H sold 34,000 shares for $22.04 per share. The transaction valued at 749,357 led to the insider holds 42,681 shares of the business.

EASTHAM KARIN sold 18,750 shares of VCYT for $427,044 on Mar 16. The Director now owns 23,451 shares after completing the transaction at $22.78 per share. On Mar 15, another insider, Anderson Bonnie H, who serves as the Director of the company, sold 34,000 shares for $22.76 each. As a result, the insider received 773,888 and left with 53,967 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 1.69B and an Enterprise Value of 1.52B. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.10 while its Price-to-Book (P/B) ratio in mrq is 1.74. Its current Enterprise Value per Revenue stands at 4.89 whereas that against EBITDA is -393.21.

Stock Price History:

Over the past 52 weeks, VCYT has reached a high of $32.40, while it has fallen to a 52-week low of $14.92. The 50-Day Moving Average of the stock is 22.74, while the 200-Day Moving Average is calculated to be 22.95.

Shares Statistics:

It appears that VCYT traded 706.60K shares on average per day over the past three months and 648.21k shares per day over the past ten days. A total of 72.18M shares are outstanding, with a floating share count of 71.03M. Insiders hold about 0.70% of the company’s shares, while institutions hold 105.46% stake in the company. Shares short for VCYT as of Apr 27, 2023 were 3.7M with a Short Ratio of 3.70M, compared to 3.9M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.10% and a Short% of Float of 5.80%.

Earnings Estimates

As of right now, 8 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.17, while EPS last year was -$0.13. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.15 and low estimates of -$0.21.

Analysts are recommending an EPS of between -$0.51 and -$0.69 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.4, with 8 analysts recommending between -$0.21 and -$0.57.

Revenue Estimates

In the current quarter, 8 analysts expect revenue to total $83.02M. It ranges from a high estimate of $85.4M to a low estimate of $80.9M. As of the current estimate, Veracyte Inc.’s year-ago sales were $72.86M, an estimated increase of 13.90% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $82.07M, an increase of 8.60% less than the figure of $13.90% in the same quarter last year. There is a high estimate of $83.4M for the next quarter, whereas the lowest estimate is $78.98M.

A total of 9 analysts have provided revenue estimates for VCYT’s current fiscal year. The highest revenue estimate was $338.42M, while the lowest revenue estimate was $330.91M, resulting in an average revenue estimate of $335.7M. In the same quarter a year ago, actual revenue was $296.54M, up 13.20% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $381.15M in the next fiscal year. The high estimate is $385.24M and the low estimate is $375.49M. The average revenue growth estimate for next year is up 13.50% from the average revenue estimate for this year.